Arrowhead Pharma (ARWR) PT Lowered to $81 at BofA Securities

March 26, 2026 11:12 AM

BofA Securities analyst Jason Gerberry lowered the price target on Arrowhead Pharma (NASDAQ: ARWR) to $81.00 (from $84.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found